And indeed, upon USP28 inhibition we observed downregulation of c-MYC protein levels in primary CLL cells, which suggests that USP28 mediates modulation of c-MYC in primary CLL cells as well. The gene discussed is MYC; the disease is B-cell chronic lymphocytic leukemia.